Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
35,071
Value
$18.8M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of MDGL by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202635,071$18.8M<0.1%+4,932+16.4%AddedHolders
Q1 202630,139$15.8M<0.1%−58,415−66.0%ReducedHolders
Q4 202588,554$51.6M<0.1%−7,628−7.9%ReducedHolders
Q3 202596,182$44.1M<0.1%−15,799−14.1%ReducedHolders
Q2 2025111,981$33.9M<0.1%+12,975+13.1%AddedHolders
Q1 202599,006$32.8M<0.1%+75,162+315.2%AddedHolders
Q4 202423,844$7.36M<0.1%+23,844NewHolders
Q3 20240$00.0%−947−100.0%Sold outHolders
Q2 2024947$265.3K<0.1%−5,114−84.4%ReducedHolders
Q1 20246,061$1.62M<0.1%−9,561−61.2%ReducedHolders
Q4 202315,622$3.61M<0.1%+9,708+164.2%AddedHolders
Q3 20235,914$863.7K<0.1%+316+5.6%AddedHolders
Q2 20235,598$1.29M<0.1%−19,340−77.6%ReducedHolders
Q1 202324,938$6.04M<0.1%−128,500−83.7%ReducedHolders
Q4 2022153,438$44.5M0.1%+130,458+567.7%AddedHolders
Q3 202222,980$1.49M<0.1%+799+3.6%AddedHolders
Q2 202222,181$1.59M<0.1%−585−2.6%ReducedHolders
Q1 202222,766$2.23M<0.1%−9,726−29.9%ReducedHolders
Q4 202132,492$2.75M<0.1%−5,732−15.0%ReducedHolders
Q3 202138,224$3.05M<0.1%+16,812+78.5%AddedHolders
Q2 202121,412$2.09M<0.1%+13,694+177.4%AddedHolders
Q1 20217,718$903.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.